Compared with cells at highest TRIM8 levels, lowest TRIM8 expression levels related to a relevant risk of death and disease development in WHO grade III tumors, indicating that a loss of TRIM8 expression may be required for the transformation to a more aggressive phenotype typical of WHO grade III gliomas. The gene discussed is TRIM8; the disease is central nervous system cancer.